In the above noted manuscript, the mutation was erroneously described as c.3385\_3386delTT. It should have been described as c.3386\_3387delTT. While both designations describe the deletion of two thymidine residues within a string of three thymidines, the mutation nomenclature [den Dunnen and Anton
Gonadal mosaicism in severe Pallister-Hall syndrome
โ Scribed by Ng, David ;Johnston, Jennifer J. ;Turner, Joyce T. ;Boudreau, Eilis A. ;Wiggs, Edythe A. ;Theodore, William H. ;Biesecker, Leslie G.
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 264 KB
- Volume
- 124A
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recently we published a review about genetic counseling and the provision of risk information in Angelman syndrome (AS) ]. However, since then, new evidence indicates that gonadal mosaicism may affect recurrence risk in the subset of AS patients who are affected as the result of UBE3A gene mutations
Pallister-Hall syndrome (PHS) comprises hypothalamic hamartoma, polydactyly, pituitary dysfunction, laryngotracheal cleft, imperforate anus, and other anomalies. Some patients with PHS have a bifid epiglottis, a rare malformation. Greig cephalopolysyndactyly syndrome (GCPS) comprises polydactyly wit